on Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG Reports Financial Results for 2024
Vitruvia Medical AG has announced its financial results for the year ending December 31, 2024. The company reported a post-tax loss of CHF 173,775.93, an improvement from the previous year’s loss of CHF 243,896.10.
The Swiss firm, specializing in medical devices and surgical instruments, achieved consolidated revenues of EUR 2,108,483.00, marking a 20% increase from the previous year. Their EBITA reached EUR 178,398.00, a significant rise of 192% compared to EUR 61,078.00 in 2023.
Earnings after taxes and goodwill amortization stood at EUR -384,086.00, an improvement over the previous year’s EUR -535,435.00. The company anticipates continued growth in 2025, driven by LT Technologies' expected increased activity.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Vitruvia Medical AG news